Identification
Personal identification
- Full name
- Miguel Gomes Cardoso
Citation names
- Cardoso, Miguel
Author identifiers
- Ciência ID
- BB16-EC1F-F9CC
- ORCID iD
- 0000-0002-2566-4925
- Researcher Id
- ABD-1410-2021
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Portuguese (Mother tongue) | |||||
English | Upper intermediate (B2) | Proficiency (C2) | Advanced (C1) | Proficiency (C2) |
Education
Degree | Classification | |
---|---|---|
2021/01/01 - 2025
Ongoing
|
Farmácia (Doutoramento)
Major in Microbiologia
Universidade de Lisboa Faculdade de Farmácia, Portugal
Universidade de Brasília Faculdade de Medicina, Brazil "Antibodies and peptides against SARS-CoV-2 infection - from ICU patients to therapy" (THESIS/DISSERTATION)
|
|
2015/10 - 2017/12
Concluded
|
Ciências Biofarmacêuticas (Mestrado)
Major in Sem especialização
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Novel Strategy to Detect and Localize Latent HIV Reservoirs" (THESIS/DISSERTATION)
|
17 valores |
2012/09 - 2015/07
Concluded
|
Bioquímica (Licenciatura)
Universidade de Lisboa Faculdade de Ciências, Portugal
"n/a" (THESIS/DISSERTATION)
|
14 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2018/01/01 - 2020/12/31 | Research Assistant (Research) | Universidade de Lisboa - Associação para o Desenvolvimento do Ensino e Investigação da Microbiologia, Portugal |
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2021/01/01 - Current | Antibodies and peptides against SARS-CoV-2 infection - from ICU patients to therapy
2020.08317.BD
PhD Student Fellow
Universidade de Lisboa Faculdade de Farmácia, Portugal
Universidade de Brasília Faculdade de Medicina, Brazil |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2020/01 - 2020/12/31 | Desenvolvimento de anticorpos para degenerescência macular
BI-VisionAb
Research Fellow
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
TechnoPhage SA
Concluded
|
2018/01 - 2019/12 | Immunogenicity in Fabry disease: the role of enzyme replacement therapy
IIR-PRT-001425
Research Fellow
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
Shire Plc
Concluded
|
Outputs
Publications
Journal article |
|
Thesis / Dissertation |
|
Activities
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2020/03/31 - Current | Here I have been working directly with patients' samples, where I perform samples inactivation (in a BSL-3 environment) and
subsequently RNA extraction, and prepare and carry out the qRT-PCR. The daily volume of processed samples has been roughly
300.
Other
|
Centro Diagnóstico COVID-19
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/02/13 - 2020/02/13 | This workshop was divided in two sessions. The first one was focused on the FlowJo's basic functions. The second session we
learned more advanced features and tools to use to analyze flow cytometry data.
Workshop
|
FlowJo Workshop
Instituto Gulbenkian de Ciência, Portugal
|
Mentoring / Tutoring
Topic | Student name | |
---|---|---|
2018/09 - 2022 | Building a Synthetic Cell System for IgG Production and Selection | Andreia Saruga |
2019/10 - 2020/04 | Engineered Bispecific CAR-T Cells for Specific Discovery in Breast Cancer | Carolina Palma |
2017/09 - 2018/09 | Proimmunotoxin: a novel design strategy of immunotoxins applied to breast cancer | Ana Margarida Manuel |
2017/09 - 2018/09 | Selection of Synthetic IgG Libraries by CRISPR Induced Variability | Jéssica Nereu |
2017/03 - 2017/07 | Using Cells as Biosensors | Ana Patrícia Vigarinho de Jesus Almeida |